A patient advocacy group is suing the Trump administration for failing to disclose details of a recent settlement with Gilead Sciences over the patent rights to a pair of HIV prevention pills. The deal, which was reached last January, capped several years of litigation that began when the Centers for Disease Control and Prevention argued…
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which…
President Trump escalated his demands that pharma companies lower U.S. drug prices in line with what other countries pay, sending letters to 17 major drug companies Thursday that called on them to take actions by Sept. 29. He specifically asked the firms to: provide their full portfolio of drugs to Medicaid patients at prices in…
The Trump administration is proposing a voluntary program in which pharmaceutical companies can offer rebates for a small number of therapies to hospitals that participate in a federal drug discount program, an effort to sort out a controversy that has roiled the health care industry. At issue is the 340B discount program, which was created…
In a closely watched case, a U.S. federal court judge has temporarily blocked a first-in-the-nation law that would prohibit companies that own pharmacy benefit managers from also operating both retail and mail-order pharmacies in Arkansas. The state law is designed to eliminate concerns that the largest pharmacy benefit managers — which are controlled by CVS Health,…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. RFK Jr. found a bench at the FDA engraved with the message: “The devil has got hold of the food supply of this country.”…